Factors associated with clinical severity in Emergency Department patients presenting with symptomatic SARS-CoV-2 infection

INTRODUCTION

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first reported in the United States in January 2020. Since then, there have been 7.5 million cases of SARS-CoV-2 infection with over 210,000 deaths in the US and rising.¹ The clinical course of coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, ranges widely in severity from asymptomatic to life-threatening. The mechanism behind this wide variation in patient outcomes is not yet well understood. Many studies thus far have documented associations between underlying patient comorbidities and more severe disease prognoses.^2-5 In addition, reports suggest that Black and Hispanic populations are disproportionately impacted by COVID-19 disease with increased rates of infection compared to white populations.^6-8 Understanding the reason for disparities among different patient populations is critical for targeting interventions aimed at mitigating the impact of disease. The objective of this study was to evaluate race, ethnicity, comorbidities, and insurance status as predictors of illness severity in patients presenting to the ED with symptomatic SARS-CoV-2 infection.

METHODS

Statistical Analysis

Data was initially stratified to identify significant associations by three categories of disposition: convalesce at home, admit to general medical service, and admit to intensive care unit (ICU) care. Patients who were initially discharged but then returned to the ED and needed admission were classified in the hospital admission category. Patients who were first admitted to the general wards but ultimately were transferred to ICU were included in the ICU category. Descriptive statistics were used to describe the demographics and comorbidities of patients per disposition. Frequencies and proportions were generated for categorical variables. Continuous variables were described using means and standard deviations. Methods for bivariate analyses were Chi-square or Fisher’s exact test for categorical data and analysis of variance (ANOVA) for continuous data.

Prior to regression analysis, variables were selected based on clinical knowledge and p-values <0.1 from bivariate analyses. We ran two separate logistic regression models: hospital admission vs. ED discharge and ICU care vs. general medical service admission. Independent variables included age, sex, race, ethnicity, health insurance, and comorbidities with need for hospitalization. In both models, patients who died within 30 days of the index visit were included in the more severe category (i.e. either needing hospital admission or ICU care). Adjusted odds ratios (aOR) and the associated 95% confidence intervals (95% CI) were reported; p-values <0.05 were considered statistically significant. All analyses were completed using SAS 9.4 (SAS Institute, Cary, NC).

RESULTS

993 ED patients with viral syndromes and positive SARS-CoV-2 PCR assays were treated in the ED between March 12-August 9, 2020. Of these, 553 (55.7%) were discharged from the ED 370 (37.2%) were admitted to the floor, and 70 (7.0%) were admitted to the ICU. Descriptive statistics of patients were performed for all three categories (Table 1). Characteristics with statistically significant differences in disposition were age, race, ethnicity, and health insurance. In addition, there was statistically significant variation in disposition for multiple comorbid conditions: diabetes mellitus, hypertension, ischemic heart disease, obesity, hyperlipidemia, heart failure, atrial fibrillation, cancer, chronic obstructive pulmonary disease (COPD), and non-specified lung disease. When analyzed by logistic regression, age and health insurance were independent predictors of hospital admission (Table 2). Patients above the age of 40 were more likely to be admitted (40-64: aOR 2.1, 95% CI 1.4-3.4; ≥65: aOR 5.1, 95% CI 2.7-9.5) compared to those under 40. For patients with public health insurance, the odds ratio of being admitted were also significantly higher (Medicaid: aOR 3.4, 95% CI 2.2-5.4; Medicare: aOR 2.6, 95% CI 1.2-5.3; Medicaid and Medicare: aOR 3.6, 95% CI 2.1-6.2) than that of patients with private/commercial health insurance. Notably, neither race nor ethnicity were independent predictors of admission (Table 2). Of the comorbid conditions analyzed, diabetes mellitus, hypertension, obesity, hyperlipidemia, and heart failure were predictors of hospital admission (Table 2). Odds of admission or death were 1.6 (95% CI 1.1-2.5) times higher for patients with diabetes mellitus, 1.8 (95% CI 1.2-2.7) times higher for patients with systemic hypertension, 1.7 (95% CI 1.1-2.5) times higher for obese patients, 1.8 (95% CI 1.2-2.9) times higher for patients with hyperlipidemias, and 3.90 (95% CI 1.4-11.2) times higher for patients with heart failure when compared to previously healthy patients. When only admitted patients were analyzed to determine predictors of need for ICU care, patients with Medicaid were 2.2 times (95% CI 0.9-5.11) more likely to need ICU care compared to patients with private or commercial insurance (Table 3). A comorbid diagnosis of COPD also predicted need for ICU admission versus general medical service admission (aOR 2.5, 95% CI 1.01-6.1).

DISCUSSION

In this case-series of 993 patients presenting to an ED with symptomatic COVID-19, we identified both comorbidities and public insurance as predictors of illness severity. A history of hypertension, diabetes, heart failure, and hyperlipidemia were significant predictors disease severity. While Black patients were disproportionately represented in the cohort of patients requiring hospital admission or ICU care, this association was no longer evident after adjusting for insurance status and comorbidities.

Prior literature has shown that Black patients may have more severe disease that whites with COVID-19.^6,10-13 Some sources suggest a bio-racial differential in immune response as the impetus for this disparity.¹⁰ When we adjusted our analysis for multiple factors including age, sex, ethnicity, health insurance, and comorbidities, the severity of illness in Black patients was not significantly different than White patients. Our study suggests that Black patients are at higher risk for severe COVID-19 outcomes due to the disproportionate burden of social determinates of health and chronic diseases such as hypertension, diabetes, and hyperlipidemia.^14,15

In our population, public insurance, specifically Medicare or Medicaid, was an independent risk factor for severe COVID-19. The association between insurance type and severe COVID-19 persisted even when controlling for comorbidities. There are several possible reasons for this association. Firstly, it is possible that patients on public insurance may have more poorly controlled chronic conditions compared to patients with private insurance. Second, patients who experience poverty, and therefore are more likely to rely on Medicaid public insurance, may present later to the ED than those with private insurance in part due to decreased accessibility to outpatient healthcare.^16-18

Third, public insurance may be associated with other unmeasured social determinants of health related to concerns about lost employment time, need for childcare, increased distance from the ED, and lack of transportation.^19-22

When comparing the two models, we identified multiple independent risk factors for predicting need for admission versus discharge that were not identified when predicting need for general hospital admission versus ICU care. It is possible that patients who are sick enough to meet the threshold for general hospital admission (moderate severity) have similar risk factors to the patients who meet the higher threshold of ICU care (high severity). It is also possible that if the sample size for admitted patients was larger, we would see similar predictors for need for ICU care as we saw for hospital admission.

The actual mechanisms behind why certain comorbidities are associated with more severe outcomes are not yet well-understood. Blood sugar elevations have been proposed to play a role in weakening the immune response.^23-26 The mechanistic relationship between uncontrolled hypertension and worse COVID-19 prognoses is not defined but hypertension has been associated with an increase in inflammatory markers and may be related to dysregulation of the renin-angiotensin-aldosterone axis.^27-31 The severity of COVID-19 is likely the result of a complex interaction between viral load, host sex, host age, host comorbidities, social determinants, and host and viral genetic factors. The higher rates of COVID-19 in African-American and Latino populations has raised the suggestion that genetic susceptibility may play a role in severity. There have been limited studies suggesting a genetic predisposition to disease severity. One case report described SARS-CoV-2 deaths in three previously healthy adult brothers suggesting a genetic predisposition due to familial clustering.³² A second case report of SARS-CoV-2 of a large family cluster with more severe disease compared to other patients presenting at the same time also suggested a genetic predisposition due to apparent familial clustering of severity.³³ Further research is needed to describe the role that host genetic factors play a role in disease susceptibility.³⁴

Conclusion

Predictors of disease severity for ED patients who present with COVID-19 include age, Medicaid insurance, Medicare insurance, diabetes mellitus, hypertension, obesity, hyperlipidemia, and heart failure. Greater understanding of the factors that contribute to clinical variability in COVID-19 severity will assist in early identification of high-risk patients and enhance the precision of public health interventions.